List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 449 studies with search of: leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML);   Leukemia, Acute Lymphocytic (ALL);   Leukemia, Chronic Myelogenous (CML);   Myelodysplastic Syndrome (MDS);   Non-Hodgkin's Lymphoma (NHL)
Interventions: Drug: WT1 Peptide-Pulsed Dendritic Cells;   Drug: Donor Lymphocytes;   Drug: IL-4;   Drug: KLH;   Drug: WT1 Peptides;   Drug: Endotoxin
2 Recruiting Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia;   Myeloproliferative Disorders;   Acute Lymphocytic Leukemia;   Acute Promyelocytic Leukemia;   Acute Leukemia;   Chronic Myelogenous Leukemia;   Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Juvenile Myelomonocytic Leukemia
Interventions: Drug: Clofarabine;   Drug: Cyclophosphamide
3 Not yet recruiting Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
Conditions: Unspecified Childhood Solid Tumor, Protocol Specific;   Accelerated Phase Chronic Myelogenous Leukemia;   Acute Undifferentiated Leukemia;   Angioimmunoblastic T-cell Lymphoma;   Atypical Chronic Myeloid Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Burkitt Lymphoma;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Childhood Grade III Lymphomatoid Granulomatosis;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Myelodysplastic Syndromes;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Chronic Eosinophilic Leukemia;   Chronic Idiopathic Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Contiguous Stage II Mantle Cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Essential Thrombocythemia;   Extramedullary Plasmacytoma;   Intraocular Lymphoma;   Isolated Plasmacytoma of Bone;   Juvenile Myelomonocytic Leukemia;   Mast Cell Leukemia;   Meningeal Chronic Myelogenous Leukemia;   Noncontiguous Stage II Mantle Cell Lymphoma;   Polycythemia Vera;   Post-transplant Lymphoproliferative Disorder;   Primary Systemic Amyloidosis;   Progressive Hairy Cell Leukemia, Initial Treatment;   Prolymphocytic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Stage 0 Chronic Lymphocytic Leukemia;   Stage I Childhood Anaplastic Large Cell Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage I Childhood Large Cell Lymphoma;   Stage I Childhood Lymphoblastic Lymphoma;   Stage I Childhood Small Noncleaved Cell Lymphoma;   Stage I Chronic Lymphocytic Leukemia;   Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage I Multiple Myeloma;   Stage I Mycosis Fungoides/Sezary Syndrome;   Stage II Childhood Anaplastic Large Cell Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage II Childhood Large Cell Lymphoma;   Stage II Childhood Lymphoblastic Lymphoma;   Stage II Childhood Small Noncleaved Cell Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage II Multiple Myeloma;   Stage II Mycosis Fungoides/Sezary Syndrome;   Stage III Childhood Anaplastic Large Cell Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage III Childhood Large Cell Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage III Childhood Small Noncleaved Cell Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Multiple Myeloma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage IV Childhood Anaplastic Large Cell Lymphoma;   Stage IV Childhood Hodgkin Lymphoma;   Stage IV Childhood Large Cell Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Stage IV Childhood Small Noncleaved Cell Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome;   T-cell Large Granular Lymphocyte Leukemia
Interventions: Procedure: massage therapy;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: intervention by caregiver;   Procedure: standard follow-up care
4 Recruiting Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
Conditions: Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention: Device: Miltenyi CliniMACS CD34 Reagent System
5 Recruiting T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia;   Lymphoid Leukemia;   Chronic Myelogenous Leukemia;   Malignant Lymphoma;   Hodgkin's Disease;   Chronic Lymphocytic Leukemia;   Myeloproliferative Disorder;   Anemia, Aplastic;   Myelodysplastic Syndromes
Interventions: Drug: Fludarabine;   Drug: Melphalan;   Drug: Stem cells;   Drug: Campath
6 Recruiting Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic;   Leukemia, Lymphoblastic, Acute;   Leukemia, Myelogenous, Acute;   Juvenile Myelomonocytic Leukemia;   Dysmyelopoietic Syndromes
Interventions: Drug: Myeloablative Chemotherapy Regimen for Lymphoid Malignancies;   Drug: Myeloablative Chemotherapy Regimen for Myeloid Malignancies;   Other: Hematopoietic Progenitor Cell Transplanation (HPCT)
7 Recruiting Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL);   Leukemia, Myeloid, Acute(AML);   Leukemia, Myeloid, Chronic(CML);   Juvenile Myelomonocytic Leukemia (JMML);   Hemoglobinuria, Paroxysmal Nocturnal (PNH);   Hodgkin Lymphoma;   Lymphoma, Non-Hodgkin (NHL);   Myelodysplastic Syndrome (MDS)
Interventions: Device: CliniMACS;   Procedure: Stem cell transplantation;   Drug: Systemic chemotherapy and antibodies
8 Recruiting A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
Conditions: Acute Leukemia;   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Biphenotypic Leukemia;   Pre-leukemic Syndromes;   Monosomy 7;   Bone Marrow Clonal Malformations;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndromes;   Chronic Myelogenous Leukemia
Intervention: Other: Withdrawal of immunosuppression and donor lymphocyte infusion
9 Recruiting Bendamustine in Acute Leukemia and MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia
Intervention: Drug: Bendamustine
10 Recruiting Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation;   Drug: Melphalan;   Biological: Stem Cell Transplant (SCT);   Procedure: Anergized Cell Infusion
11 Recruiting Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Lymphoblastic, Acute;   Leukemia, Myelocytic, Chronic
Interventions: Other: Allogeneic Lymphocytes;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Methylprednisolone;   Drug: Cyclosporine
12 Recruiting Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
Conditions: Leukemia, Myelocytic, Acute;   Leukemia, Lymphocytic, Acute;   Leukemia, Myeloid, Chronic;   Myelodysplastic Syndromes
Interventions: Drug: Tacrolimus/methotrexate;   Drug: Tacrolimus/sirolimus
13 Recruiting Randomized Double Cord Blood Transplant Study
Conditions: Leukemia, Lymphocytic, Acute;   Leukemia, Myelocytic, Acute;   Leukemia, Myeloid, Chronic;   Lymphoma, Non-Hodgkin
Interventions: Procedure: Expanded allogeneic cord blood (CB);   Procedure: One Unmanipulated and One Expanded Cord Blood Unit
14 Recruiting Intraosseous Infusion of Unrelated Cord Blood Grafts
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome
Intervention: Procedure: cord blood infusion
15 Recruiting Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic;   AML;   Leukemia, Lymphocytic, Acute;   MDS;   Leukemia, Lymphocytic, Chronic;   JMML;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Multiple Myeloma
Interventions: Procedure: Stem Cell Transplant;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Busulfan
16 Recruiting Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies;   Acute Myeloid Leukemia;   Lymphoid Leukemia;   Chronic Myeloid Leukemia;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndromes
Intervention: Drug: StemEx®
17 Not yet recruiting Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Conditions: Hematopoietic/Lymphoid Cancer;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large-Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   B-cell Chronic Lymphocytic Leukemia;   Burkitt Lymphoma;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Lymphoma, Mucosa-Associated Lymphoid Tissue;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Peripheral T-Cell Lymphoma;   Prolymphocytic Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Multiple Myeloma;   Splenic Marginal Zone Lymphoma;   Waldenstrom Macroglobulinemia
Interventions: Drug: carmustine;   Drug: etoposide;   Drug: cytarabine;   Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Drug: tacrolimus;   Drug: mycophenolate mofetil;   Radiation: total-body irradiation;   Drug: melphalan;   Procedure: autologous-allogeneic tandem hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: allogeneic bone marrow transplantation;   Other: fluorescence in situ hybridization;   Other: flow cytometry;   Other: RNA analysis;   Other: laboratory biomarker analysis;   Other: cytogenetic analysis;   Other: polymerase chain reaction
18 Recruiting Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
Conditions: AML;   ALL;   Undifferentiated Leukemia;   Biphenotypic Leukemia;   Refractory Anemia;   Refractory Anemia With Ringed Sideroblasts;   Refractory Cytopenia With Multilineage Dysplasia;   Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts;   Refractory Anemia With Excess Blasts-1 (5-10% Blasts);   Refractory Anemia With Excess Blasts-2 (10-20% Blasts);   Myelodysplastic Syndrome, Unclassified;   MDS Associated With Isolated Del (5q)
Intervention: Drug: Abatacept
19 Recruiting Natural Killer Index From Hematopoietic Stem Cell Graft
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloblastic Leukemia;   Chronic Myeloid Leukemia
Intervention: Procedure: Blood test
20 Recruiting Studying Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Hematopoietic/Lymphoid Cancer;   Leukemia, Myeloid, Aggressive-Phase;   Blastic Phase Chronic Myelogenous Leukemia;   Leukemia, Myeloid;   Leukemia, Myeloid, Chronic-Phase;   Adult Acute Lymphoblastic Leukemia in Remission;   Recurrent Adult Acute Lymphoblastic Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia in Remission;   Recurrent Adult Acute Myeloid Leukemia;   Childhood Acute Myeloid Leukemia in Remission;   Recurrent Childhood Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Disease, Unclassifiable;   Childhood Myelodysplastic Syndromes;   De Novo Myelodysplastic Syndromes;   Secondary Myelodysplastic Syndromes;   HIV-associated Hodgkin Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   Anaplastic Large-Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Burkitt Lymphoma;   HIV Infections
Interventions: Procedure: leukapheresis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis;   Other: DNA analysis;   Other: RNA analysis;   Other: flow cytometry;   Other: reverse transcriptase-polymerase chain reaction;   Other: nucleic acid sequencing;   Other: protein expression analysis

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services